Nivolumab Plus Cabozantinib Demonstrates Positive Results for Renal Cell Carcinoma

Press/Media

Period	27 Feb 2023

Media coverage

Title	Nivolumab Plus Cabozantinib Demonstrates Positive Results for Renal Cell Carcinoma
Media name/outlet	Pharmacy Times
Country/Territory	United States
Date	27/02/23
URL	ct.moreover.com/?a=50116408636&p=1gw&v=1&x=ipU8ZNE7ZzmBZ5zhA_q4Lg
Persons	Mauricio Burotto